Your Recent Quotes: 0 | 0

Merck & Company Incorporated

Related Information and Financials
Price Glossary Definition
32.22
1.42%
7/24/08 4:00
Open
32.17
Prev Close
31.77
Volume
25,102,862
52 Wk. Range
31-62
Year-to-Date Performance Glossary Definition
Latest Dividend
Dividend
0.38
Yield
4.85
Ex-Date
09/03/2008
Price/Earnings Comparisons Glossary Definition
 
19.70
 
23.70
 
17.50
MRK
Sect. Av.
S&P 500
Market Cap
67,250,722,200
Outstanding Shares
2,184,276,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy MRK Rating Report
Target Price (1Yr)
High
117.00
Revenue
25.43B

Annual Dividend
Rate
1.52
Yield
4.30
Growth
12 Month
3 Year
CAGR
Revenue
6.90
0.05
0.02
Net Income
-26.10
-0.44
-0.17
EPS
-26.60
-0.42
-0.17

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-18.64
-35.19
0.61
Earnings Per Share($)

12/2005
 
 
 
2.11
12/2006
 
 
 
2.04
12/2007
 
 
 
1.51

Earnings
EBITDA
7.61B
Revenue
24.20B
Outside Analyst Rating History

7/24/08
6
Buy
7/24/08
7
Hold
7/24/08
0
Sell

Jim Cramer Portfolio
Find out now if MRK is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
  • S&P 500 (SPX.X)
  • Dow Jones (INDU)
  • Nasdaq (COMPX)
    Latest Headlines
    Jim Cramer thinks the recent negativity is overdone and there is a nice pipeline of drugs.

    02:59PM 07/23/08

    Watch Video
    Video
    Biogen Idec climbs on better-than-expected earnings.

    5:44PM 07/22/08

    Frank Curzio's guests include energy analyst Phil Flynn, and Robert Holmes on Sirius and XM Satellite.

    5:21PM 07/22/08

    After a skittish start following some disappointing earnings reports, the major market indices have bounced up to the baseline as oil slides and the dollar rallies.

    1:04PM 07/22/08

    Asia's build-out contributes to a 50% increase in Caterpillar's machinery sales.

    11:53AM 07/22/08

    Earnings reports from the likes of AmEx and Texas Instruments and guidance from Apple weigh on investor sentiment.

    9:51AM 07/22/08

    S&P 500 and Nasdaq futures drop after disappointing earnings.

    7:59AM 07/22/08

    Merck and Schering-Plough fall on concerns about a cholesterol drug.

    6:41PM 07/21/08

    The drugmaker beats Wall Street targets by 3 cents a share; however, the impact of Vytorin weighs.

    6:31PM 07/21/08

    The drugmaker beats Wall Street earnings estimates by 3 cents a share, but shares continue to fall on today's cholesterol drug trial data.

    5:45PM 07/21/08

    Understanding the Market

    Our Experts' Take at RealMoney
    The stock continues it's pattern of dipping to than jumping off of its 200-day moving average.

    3:59PM 07/24/08

    Seeking salvation down deep as I continue to prove my earnings plays leave something to be desired.

    3:31PM 07/24/08

    More Experts' Takes


    Premium Stock Ideas
    Is Cramer trading MRK in his Action Alerts Plus Portfolio?